Skip to main content
OpenTrials
Completed

NCT Number: NCT05001620

Implementation of a Telehealth Palliative Care Model for Persons With Dementia

Grounded in the Reach-Effectiveness-Adoption-Implementation-Maintenance (RE-AIM) Model, this study will assess the implementation outcomes of the Nurse Practitioner (NP) delivered telehealth Palliative Care Consultation in Post-Acute Care (PCC-PAC) intervention for persons living with dementia (PLWD) and their care-partners newly admitted to nursing homes (NHs) for post-acute care.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Palliative Care Brain Diseases Central Nervous System Diseases Dementia Mental Disorders Nervous System Diseases Neurocognitive Disorders

Age range

60 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Collingswood Rehabilitation and Healthcare Center

Rockville, Maryland, 20850, United States

About this study

This single arm embedded pragmatic pilot clinical trial will provide data to assess the implementation outcomes of the Nurse Practitioner (NP) delivered telehealth Palliative Care Consultation in Post-Acute Care (PCC-PAC) intervention among 30 persons living with dementia (PLWD) and their care-partners newly admitted to one nursing homes (NH) for post-acute care.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Stakeholders:

  • (1) PC provider
  • (2) Social Work (SW) NH champions
  • (3) post-acute care unit nursing staff and providers (including medical directors)
  • (4) NH leadership, information technology staff
  • (5) PLWD and their care partner(s).

Person Living with Dementia (PLWD)

  • documented dementia diagnosis
  • admitted for post-acute care
  • age ≥ 60 years
  • if unable to participate in a conversation or lacking capacity to make healthcare decisions as determined by the NH staff/providers, a care partner who can act as a surrogate decision maker in the PCC-PAC.

Exclusion criteria

Stakeholders:

-PLWD who receives the intervention

PLWD:

  • planned discharge within 48 hours of screening
  • currently receiving hospice care

Treatment and study plan

Palliative Care Consultation

Other

The PC provider conducts the structured PCC-PAC via videoconference or telephone with the PLWD and/or their care partner and the social work (SW) champion in the NH. The SW and PC provider will set up a mutually agreed upon consultation day/time with the PLWD and/or care partner, within 5 business days of NH admission and follow up visits will occur no more than 30 days later (if needed).

Primary outcomes

  1. Adherence to Skilled Nursing Facility (SNF)-PCC Recommendations

    Time frame: 30 days post admission

    Investigators will determine a recommendation adherence score after each participants' encounter. Each recommendation will be assigned 2 points, then will define full (2 points), partial (1 point) and no adherence (0 point) to each recommendation. Investigators will sum the points for each SNF-PCC recommendation and use this as the denominator. Investigators will sum each recommendation with full, partial, no adherence and use this as the numerator. The fraction will be converted to a percentage ranging from 0-100% reflecting the recommendation adherence score.

Secondary outcomes

  1. Number of Hospitalizations

    Time frame: 30 days post admission

    Number of hospitalization(s)

Other outcomes

  1. Number of Participants With Completed Stakeholder Interviews/Focus Groups

    Time frame: 1 year

    We engaged participants in focus groups and semi-structured interviews to deepen understanding of barriers and facilitators to telehealth palliative care implementation.

Sponsors and collaborators

Lead sponsor

University of Maryland, Baltimore

Other

Collaborators

  • National Institute on Aging (NIA)

Registry information

Acronym: IMPACT

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Aug 12, 2021
Registry last updated
Aug 13, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.